You can use your existing Medical Independent, MediLearning or PharmacistCPD account to log in. is Ireland's only investigative medical news website for doctors, healthcare professionals and anyone with an interest in health issues.

Established in 2010, along with its sister publication The Medical Independent, our stated aim is to investigate and analyse the major issues affecting healthcare and the medical profession in Ireland. The Medical Independent has won a number of awards for its investigative journalism, and its stories are frequently picked up by national digital, broadcast and print media. The Medical Independent is published by GreenCross Publishing.

Address: Top Floor, 111 Rathmines Road Lr, Dublin 6

Tel: 353 (01) 441 0024

GreenCross Publishing is owned by Graham Cooke.

The benefits of registering: only registered users:
  • receive the ecCopy two days prior to the printed edition.
  • have automatic access to our free CPD sites.
  • can partake in our online MCQs.
  • can enter our online sports quiz.

Sign up now for ease of access to The Medical Independent, Ireland’s most frequently published medical newspaper, delivering award-winning news and investigative reporting.

Download the new Mindo app for both IOS & Android.

  • Get notified when a story goes live
  • Access Premium Content
  • Read Offline
[the_ad_placement id="main-ldb-public"]
[the_ad_placement id="main-ldb-mobile-public"]

You are reading 1 of 2 free-access articles allowed for 30 days

NCCP concerned about leverage loss due to new funding arrangements

By Dermot - 15th Nov 2017 | 2 views

At a meeting of the NCCP Executive Committee in January, the minutes of which were seen by <strong><em>MI</em></strong> through Freedom of Information, it was noted that as a result of changes to the usual finance model, oncology funding has been provided in the base budgets of hospitals, rather than through the NCCP.

“It will not be visible to hospitals that funding is from NCCP, decreasing NCCP leverage,” according to the minutes.

In 2017, the majority of NCCP funding was committed up-front to the designated cancer centres.

Most of the funding in question is for staff and services.

A small amount, €3 million in the HSE National Service Plan for 2017, is reimbursed by the NCCP to the hospitals to cover growth in expenditure on cancer drugs in use prior to 2013.

The reimbursement of new high-cost cancer drugs approved since 2012 is facilitated through a separate system, the Oncology Drug Management System (ODMS).

In terms of cancer funding going into base budgets for 2017, National Director of the NCCP Dr Jerome Coffey admitted to <strong><em>MI</em></strong> recently that some hospitals had queries about their cancer funding, as it was not as “visible” as in previous years.

“The NCCP has monthly meetings with each of the cancer centres, primarily focused on clinical activity and service development,” he explained.

“In addition, it provides written details of budget allocations. Given the very significant increase in cancer incidence projected by the National Cancer Registry, the NCCP is actively planning to scale-up cancer services, primarily in the cancer centres. This approach will serve to increase leverage over time.”

It is envisaged the funding arrangements between the NCCP and hospitals will be strengthened in future years under the <em>National Cancer Strategy 2017-2026</em>.

The relevant recommendation states that: “The central role of the NCCP in ensuring that the <em>National Cancer Strategy 2017-2026 </em>is implemented across the health service will be strengthened, including through the use of Service Level Agreements, and through a direct role in financial allocations to the Hospital Groups under activity-based funding.”

Leave a Reply

[the_ad_placement id="main-ldb-public-2"]
[the_ad_placement id="main-ldb-mobile-public-2"]
Latest Issue
The Medical Independent – 24 June 2021

You need to be logged in to access this content. Please login or sign up using the links below.

[the_ad_placement id="main-mpu-public"]
Most Read
[the_ad_placement id="main-ldb-public-2"]
[the_ad_placement id="main-ldb-mobile-public-2"]